Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Analyzing tweets could help identify public health trends for influenza, depression

Tweeting could one day be used by public health officials to predict the spread of influenza in populations. Research, published in EPJ Data Science, conducted at the U.S. Department of Energy's Pacific Northwest National Laboratory, outlined how future public health workers could utilize social media to identify trends of influenza or other health issues.

Thumbnail

CMS to cancel mandatory bundles

A rule title posted to the Federal Register on Aug. 10 indicates CMS will cancel two mandatory bundled payment programs, the Advancing Care Coordination through Episode Payment Models (EPMs) and Cardiac Rehabilitation Incentive (CRI) Payment Models, while changing a separate payment program on joint replacements.

Thumbnail

Deloitte’s Chip Newton: Where your practice is overspending on labor

When it comes to finding waste in their labor costs, healthcare leaders need to sweat the small stuff, according to Chip Newton, senior manager at Deloitte Consulting LLP.

Thumbnail

ACA insurers get 3 extra weeks to file final rates for 2018

CMS has pushed back the deadline for insurers to file their final 2018 rate requests for the Affordable Care Act (ACA) exchanges until Sept. 5, giving companies extra time to decide what plans and prices to offer.

Owed $3B in Medicaid payments, Illinois providers struggle to stay open

Illinois has been ordered to prioritize paying down a $3 billion backlog of overdue Medicaid bills, but those paymentsmay  not get to providers in time to stop some of them from closing their practices.

Thumbnail

Trump to declare ‘national emergency’ on opioid crisis

Following up on recommendations by his own White House commission, President Donald Trump said he will declare a national public health emergency on the opioid addiction epidemic, which would have an impact on healthcare providers.

Libertana Home Health, Orbita team up to offer voice software care assistants

Orbita, providers of voice-first software, and Libertana Home Health, a California-based health and housing waiver management company, have teamed up to develop a home care system that uses Amazon’s Alexa voice assistant technology.

Thumbnail

ACA insurers seeking premium hikes as high as 49% due to policy uncertainty

In an analysis of what Affordable Care Act (ACA) exchange insurers are requesting to charge customers in 21 major cities in 2018, the Kaiser Family Foundation found the cost for the second-lowest silver-level plan will range from $244 to $631 per month, with most enrollees cushioned from the price hikes by federal subsidies.

Displaying 4345 - 4352 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup